
Sign up to save your podcasts
Or


TRANSCRIPT
SinglePoint (OTCQB ticker symbol SING) a fully reporting technology company, is pleased to announce it has signed an asset purchase agreement to acquire Direct Solar and AI Live Transfers. The two companies are providing what has been described as the Lending Tree Model for solar business. With the proposal of The Green New Deal, solar is at the forefront of every conversation and will continue to be top of mind as the nation grows through an “energy shift” to renewable resources such as solar.
According to Zion Market Research, the global Solar Panel Market accounted for USD $30.8 billion in 2016 and is expected to reach USD $57.3 billion by 2022, growing at a CAGR of 10.9% between 2017 and 2022.
Direct Solar has been on a hockey stick growth pattern. In the past twelve months the company has surpassed $1,500,000* in revenue with approximately 60% gross margins. In February 2019, the company generated approximately $321,230*. Direct Solar and SinglePoint estimate the four quarters following the closing of the acquisition will result in just over $8,230,000 in sales. This is based on numbers that have already been achieved without marketing budget available to the company. The following year, two projections have the company turning a profit of $2,844,288 on revenues of approximately $14,000,000.
Total installed U.S. PV capacity is expected to more than double over the next five years, and by 2023, over 14 GW of PV capacity will be installed annually. This represents a major opportunity for SinglePoint and Direct Solar to exponentially grow and establish a leadership role within the new segment of the burgeoning solar industry.
The asset purchase agreement has been signed, and upon the completion of the audit, the transaction will be completed. SinglePoint plans to start recognition of these revenues around the end of April. Quote, “This is a phenomenal opportunity for SinglePoint. This changes the entire financial fundamentals for the company and enables us to continue to push forward with opportunities to continue increasing shareholder value and the overall value of SinglePoint,” end quote, said Wil Ralston, President, SinglePoint Inc.
Direct Solar is able to move into every state quickly and efficiently because of the proprietary online education technology the company has developed. SinglePoint plans to utilize this edge to pitch Cannabis businesses on the opportunity to save money and increase margins through lowering the cost of utilities through the use of solar.
***
This episode is brought to you via Stock Wave - a production company that provides audio & video services to variety of clients. Stock Wave may have been compensated for the production of this audio service.
In trading, there can be no assurance that any prior successes or past results as to income earnings can be used as an indication of future success or results. Audio/video services by Stock Wave are for informational purposes only and do not purport to be a complete study of the featured company or other companies mentioned. Information used and statements of fact have been obtained from the featured company and other sources, but not verified nor guaranteed by Stock Wave, as to completeness or accuracy.
Listeners are advised to use caution and seek the advice of qualified professionals before acting on any information provided by Stock Wave’s audio/video services. Listeners are also advised to perform their own due diligence when it comes to making investment decisions.
TRANSCRIPT
Diego Pellicer Worldwide, Inc. (OTCQB:DPWW) the premium marijuana brand and management company, today announced that Diego Pellicer took top national honors at the 2018 Cannabis Business Awards, receiving two CBA Globe awards in the sought-after categories of retail and branding.
Diego Pellicer was awarded “Most Valuable Brand of the Year” beating out tough national competition including MedMenTM, The Clinic, Lightshade and Olio. Diego was also honored as the “Best Retail Center” for the second year in a row, defeating other highly regarded names including LiveWell, The Clinic, The Green Solutions, Euflora and Kind Love.
“The Cannabis Business Awards are the most prestigious awards in the multi-billion dollar cannabis industry. This is such an honor for Diego Pellicer,” said Ron Throgmartin, CEO of Diego Pellicer Worldwide, Inc. “We’ve known the power of Diego’s premium brand and progressive business model – these two CBA Globe awards demonstrate that Diego customers appreciate the world-class experience that Diego Pellicer provides and the industry recognizes our leading management model.”
CBA Globes Presented at Exclusive Event in Colorado
The CBA Globe awards were presented to Throgmartin and Neil Demers, CEO of Diego Pellicer – Colorado, at an exclusive evening event at the Hilton Ballroom in downtown Denver on December 5, 2018. The red carpet event was packed with the top business executives, trailblazers and thought leaders in the cannabis industry.
“This is monumental. These awards are the pinnacle of the profession, recognizing the best of the best,” said Demers. “The premium Diego Pellicer branded stores feature the finest products, hospitality level quality service in an approachable, world-class environment. We are truly honored to have been nominated by so many and to receive two prestigious CBA Globe Awards.”
Since 2011, Chloe Villano and Clover Leaf have been producing the Cannabis Business Awards to honor cannabis professionals deserving of historical recognition and esteemed accolades for industry progression and innovation. The national Cannabis Business Awards are presented to cannabis industry businesses, individuals and organizations in both medical and recreational sectors, as well as ancillary industries.
About Diego Pellicer Worldwide, Inc. (OTCQB:DPWW)
Diego Pellicer Worldwide, Inc. is the premium marijuana brand and management company. In addition to its branded locations in Colorado and Washington, the company actively seeks to develop and manage high-end, turnkey cannabis retail stores. When federally legal, DPWW is positioned to become a national, vertically integrated marijuana company. To learn more about how to become a branded Diego Pellicer retailer, cultivator or investor visit www.Diego-Pellicer.com
***
This episode is brought to you via Stock Wave - a production company that provides audio & video services to variety of clients. Stock Wave may have been compensated for the production of this audio service.
In trading, there can be no assurance that any prior successes or past results as to income earnings can be used as an indication of future success or results. Audio/video services by Stock Wave are for informational purposes only and do not purport to be a complete study of the featured company or other companies mentioned. Information used and statements of fact have been obtained from the featured company and other sources, but not verified nor guaranteed by Stock Wave, as to completeness or accuracy.
Listeners are advised to use caution and seek the advice of qualified professionals before acting on any information provided by Stock Wave’s audio/video services. Listeners are also advised to perform their own due diligence when it comes to making investment decisions.
SinglePoint (OTCQB ticker symbol SING) a fully reporting company tied into technology and cannabis has signed a letter of intent to raise up to $12,000,000. The capital comes on favorable terms to the company and is only available at the company’s discretion. Final terms are still being negotiated, upon execution of the agreement SinglePoint will file a registration statement with the SEC. Continuing the company’s pursuit of transparency and increasing value for its shareholders, this raise will help SinglePoint access capital for continued growth and to complete acquisitions in currently in negotiation.
Greg Lambrecht, SinglePoint CEO stated, quote, “The goal for SinglePoint is to raise capital at the best terms we can in order to capitalize on the host of opportunities we have in the hemp derived CBD space. We are already filling multiple orders and will be able to expand our sales and marketing as well as receive the best pricing from our suppliers with larger purchase orders.” End quote.
The company has been highly focused on the hemp market. From selling finished products on SingleSeed.com to bulk sales of raw material. SingleSeed has been establishing its footprint in the supply chain of the hemp derived CBD market. Additionally, the company has invested in TorusMed a business setting out to produce specific strains of CBD through commercial size photobioreactors.
According to a new estimate from cannabis industry analysts the Brightfield Group, the hemp-CBD market alone could hit $22 billion by 2022. SinglePoint through its subsidiary SingleSeed is tapping into this market through the expansion into multiple services and products offered.
***
This episode is brought to you via Stock Wave - a production company that provides audio & video services to variety of clients. Stock Wave may have been compensated for the production of this audio service.
In trading, there can be no assurance that any prior successes or past results as to income earnings can be used as an indication of future success or results. Audio/video services by Stock Wave are for informational purposes only and do not purport to be a complete study of the featured company or other companies mentioned. Information used and statements of fact have been obtained from the featured company and other sources, but not verified nor guaranteed by Stock Wave, as to completeness or accuracy.
Listeners are advised to use caution and seek the advice of qualified professionals before acting on any information provided by Stock Wave’s audio/video services. Listeners are also advised to perform their own due diligence when it comes to making investment decisions.
SinglePoint (OTCQB:SING) a fully reporting technology company providing mobile payments, ancillary cannabis services and blockchain solutions prepares for 2019 and provides insight to company direction as well as acquisitions that the company will pursue. Additionally, the company provides insight to previous acquisitions it has completed and the successes of those to date.
Most recently the company has had major success in its industrial hemp CBD related initiatives. SingleSeed.com a subsidiary of SinglePoint has steadily increased volume of orders which the company believes will be a major component of increased revenue in 2019. This week the company has been optimizing different landing pages and utilizing tools such a heat maps and A/B testing to target site visitors overall experience to refine and work on increasing conversion as well as site visits. SingleSeed will also continue to add new products and plans to add CBD for pets in the near future.
The Hemp Business Journal estimates the industrial hemp CBD market totaled approximately $190 million last year, a brand new category that didn’t even exist a few years ago. By 2022, the Brightfield Group, a cannabis and CBD market research firm, says sales are expected to reach $22 billion. Making this possible is the passing of 2018 farm bill; the measure amended the term “marihuana” to exempt hemp so long as it has no more the .3 percent THC, as a controlled substance.
In addition to the success of SingleSeed, SinglePoint has invested in TorusMed a company working to develop CBD using photobioreactors. This process would significantly reduce cost and time of producing specific strains extracted from industrial hemp. The goal of the project is to ultimately have CBD that is pharmaceutical grade and cultivated in lab settings to ensure consistency. This project has the opportunity to change the way industrial hemp and CBD are manufactured. Working with leading researchers and industry leaders SinglePoint believe this will pan out to be a very good investment for the company. SinglePoint has previously been successful in these types of investments such as Jacksam which SinglePoint has approximately 10% ownership in with the company currently valued at approximately $120,680,778 as of 1-9-2019.
SinglePoint management will continue to look for new acquisitions and investment opportunities. To date the company is in discussions with potential opportunities that will drive revenue and solidify SinglePoint position in the industrial hemp CBD market. These opportunities include producing industrial hemp, manufacturing products as well as distribution. To bolster distribution SinglePoint will be attending expo’s this year to align distribution deals and build out account growth distributing the products currently available on SingleSeed.com. The company has also started to build out a sales team to target convenience store owners, vape shops, liquor stores and more to sell products directly into these accounts.
While the company has high hopes and big plans for the CBD market and the potential growth, it has continued to build upon initiatives that were already set in place.
Previous acquisitions such as ShieldSaver and DIGS continue to grow and provide opportunities for SinglePoint to expand. ShieldSaver has completed its first mobile application to support the company’s efforts. In January the company will launch the service in Sacremento International Airport as well as WallyPark at Denver International Airport. ShieldSaver has many companies in the pipeline to continue growth. The agreement with WallyPark and Sacramento will serve as baselines to the additional opportunities. “ShieldSaver has a massive opportunity to exponentially grow as it provides major value to both customers and the lot owners using our service. We have first mover advantage to take this trojan horse into major account through the US and Internationally as we expand,” states Dan Shikiar ShieldSaver founder.
Driving these opportunities has been the ability for SinglePoint to raise capital on terms beneficial to the company. Having become fully reporting almost one year ago SinglePoint management has been able to facilitate new funding on terms more favorable to the company. Recently SinglePoint signed a deal to raise up to $5,000,000. Along with these acquisitions that bolster revenue and profit the company may have the opportunity to continue improving funding opportunities to drive is acquisition strategy. Quote, “2019 will be a banner year for SinglePoint we are equipped with the proper funding, partners and opportunities to be firing on all cylinders. We as a team expect to position SingleSeed and SinglePoint as market leads in the CBD market while continuing to enable to founders of the companies we have acquired grow their businesses. We are well diversified and have large opportunities across many emerging markets that should enable us to be successful into 2019 and beyond,” end quote, states Greg Lambrecht CEO SinglePoint.
If you have questions, opportunities or just want to say hi, please reach out to [email protected]
This episode is brought to you via Stock Wave - a production company that provides audio & video services to variety of clients. Stock Wave may have been compensated for the production of this audio service.
In trading, there can be no assurance that any prior successes or past results as to income earnings can be used as an indication of future success or results. Audio/video services by Stock Wave are for informational purposes only and do not purport to be a complete study of the featured company or other companies mentioned. Information used and statements of fact have been obtained from the featured company and other sources, but not verified nor guaranteed by Stock Wave, as to completeness or accuracy.
Listeners are advised to use caution and seek the advice of qualified professionals before acting on any information provided by Stock Wave’s audio/video services. Listeners are also advised to perform their own due diligence when it comes to making investment decisions.
SinglePoint Inc. (OTCQB:SING) a fully reporting company is pleased to announce its investment in TorusMed Inc. to develop CBD Cell Cultures from industrial hemp. Recently the 2018 Farm Bill was passed, opening a vast array of opportunities. SinglePoint plans to quickly acquire and invest in companies dealing directly within the now legalized industrial hemp market.
The goal of the project is to ultimately have CBD that is pharmaceutical grade and cultivated in lab settings to ensure consistency. This project has the opportunity to change the way industrial hemp and CBD are manufactured, reducing time, cost and valuable resources while increasing consistency, safety and scalability of the plant.
The specific aim is to develop the optimal protocols for the mass production of CBD from cell cultures of industrial hemp. The production of CBD from cell cultures is far more advantageous than from open-field farm cultivation of industry hemp for the following reasons: (1) independence from outside weather and seasonal climatic conditions; (2) environmentally-controlled production system in laboratory flasks and in scalable industrial photobioreactors; (3) optimal protocols for cell biomass growth and CBD production; (4) greater resource-use efficiency in terms of water, land nutrients, etc.; (5) greater convenience and efficiency in scale up of production in terms of using scalable industrial photobioreactors, among others.
The specific objectives of the study include: (1) To develop and establish cell cultures of industrial hemp both in the form of callus cells and of liquid cell suspension cultures; (2) To optimize the biomass growth of the cell suspension cultures in terms of nutrient media, light intensity, light quality and carbon dioxide (CO2) enrichment; (3) To optimize the CBD yield of the cell suspension cultures in terms of nutrient media, light intensity, light quality, and carbon dioxide (CO2) enrichment; and (4) To demonstrate the cultivation of the cell suspension cultures in scalable Photobioreactors. The specific aim for a potential Year 2 for the study is to develop the protocols for the cultivation of the cell cultures and production of CBD in industrial-scale Photobioreactors.
According to New Frontier Data, “The 2018 Farm Bill will restore industrial hemp to nationwide legal production for the first time since World War II, offering vast opportunities for the industry and investment in a market expected to triple in four years.”
With the removal of hemp from federal prohibition under the Controlled Substances Act of 1970 (CSA), the total U.S. hemp industry now looks to expand at a healthy 18.4% through a 5-year combined annual growth rate (CAGR) from 2018-2022. New Frontier Data’s Hemp Business Journal estimates that, in leading all hemp product categories, the hemp-derived CBD market will grow from a $390 million-dollar market in 2018, to a $1.3 billion market (or 3.3x) by 2022, representing a 27.2% 5-year CAGR.
Upon completion of the development, SinglePoint plans to distribute this premium CBD. Currently the company is working with producers and manufacturers to distribute industrial hemp CBD through its ecommerce site SingleSeed.com. SinglePoint plans to grow this distribution force to both retail and other channels to increase revenue and sales through the subsidiary.
This episode is brought to you via Stock Wave - a production company that provides audio & video services to variety of clients. Stock Wave may have been compensated for the production of this audio service.
In trading, there can be no assurance that any prior successes or past results as to income earnings can be used as an indication of future success or results. Audio/video services by Stock Wave are for informational purposes only and do not purport to be a complete study of the featured company or other companies mentioned. Information used and statements of fact have been obtained from the featured company and other sources, but not verified nor guaranteed by Stock Wave, as to completeness or accuracy.
Listeners are advised to use caution and seek the advice of qualified professionals before acting on any information provided by Stock Wave’s audio/video services. Listeners are also advised to perform their own due diligence when it comes to making investment decisions.
Few companies that closed strong last year - revisiting latest news from Phoenix Life Sciences, Repro Med Systems, Publicis Groupe and few others.
Phoenix Life Sciences International Limited (PLSI), an international adaptive healthcare solutions company, today announced that Mohyuddin Mirza has joined the company as the Botany Specialist.
Dr. Mohyuddin Mirza has over three decades of experience in the management of greenhouse crops from farm to consumers including Echinacea, Rhodeola, and Cannabis and has made a significant economical impact on the botanical products industries in Alberta, Canada. He pioneered the industry by introducing hydroponics and soilless crop production to indoor growing and played a pivotal role in growing the greenhouse industry from a $25 million to $160 million business from 1980 to 2014. He is the recipient of Alberta Agriculture Hall of Fame in 2014
Repro Med Systems (OTCQX:REPR) today announced that certain of its stockholders (the "Selling Stockholders") including Mr. Andy Sealfon and Dr. Paul Mark Baker, both Directors of the Company, entered into an agreement for the private placement sale of 11,101,697 shares of the Company's common stock at a price of $1.20 per share. Purchasers in the transaction included new institutional investors and an existing affiliate of the Company. The Selling Stockholders will receive all of the proceeds from this transaction. No shares will be issued, offered or sold by the Company.
Mr. Sealfon and Dr. Baker will have resigned from the Company's Board of Directors effective with the first closing of the sale, which the Company expects to occur on or prior to December 19, and have entered into separation agreements with the Company. They will no longer own any shares of RMS common stock following the closing of the transaction. In addition, RMS agreed to file a registration statement within 45 days to cover the purchasers' resale of the shares.
Publicis Groupe (OTCQX:PUBGY and PGPEF), announces that it is entering into exclusive negotiations with the founding shareholders of Soft Computing, a leading data marketing firm in France, with a view to the acquisition of a controlling block representing 82.99% of the share capital at a price of 25 euro per share (2018 coupon attached), i.e. at a premium of 66,66% to the closing price on December 19, 2018.
Created in 1984 by Eric Fischmeister and Gilles Venturi, Soft Computing is specialized in Data and how it is applied to enhance marketing and transform the customer experience. With over 400 experts, this market leading company provides its services to the majority of large corporates in the retail, services and financial sectors.
Hut 8 Mining Corp. (OTCQX ticker symbol HUTMF), one of the world’s largest public cryptocurrency mining company by operating capacity and market capitalization, announced today, further to its previously announced purchase of 16 BlockBox AC data centers from Bitfury Holding the issuance of 2,133,858 common shares of the Company to Bitfury, at an issuance price of $3.75 per common share, in satisfaction of 40% of the purchase price for such BlockBox AC data centers announced on September 7th, 2018.
Smith-Midland Lands largest SlenderWall Project Ever Produced, the corporation announced early January. Architects Marchetto Higgins Stieve, Owner Developer Hartz Mountain Industries and General Contractor Katerra have chosen Smith-Midland to manufacture and install their SlenderWall envelope system for the new 800 Harbor Boulevard project at Lincoln Harbor in Weehawken, NJ. The expansive 586 luxury residential waterfront rental apartment building will incorporate over 157,000 square feet of white acid-etch finished SlenderWall panels. This project marks the largest deployment of SlenderWall panels in the product's 27 year history. Smith-Midland has previously worked with Marchetto Higgins Stieve on the Port Imperial, NJ Nine on the Hudson multi-family project which opened in mid-2018.
This episode is brought to you via Stock Wave - a production company that provides audio & video services to variety of clients. Stock Wave may have been compensated for the production of this audio service.
In trading, there can be no assurance that any prior successes or past results as to income earnings can be used as an indication of future success or results. Audio/video services by Stock Wave are for informational purposes only and do not purport to be a complete study of the featured company or other companies mentioned. Information used and statements of fact have been obtained from the featured company and other sources, but not verified nor guaranteed by Stock Wave, as to completeness or accuracy.
Listeners are advised to use caution and seek the advice of qualified professionals before acting on any information provided by Stock Wave’s audio/video services. Listeners are also advised to perform their own due diligence when it comes to making investment decisions.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a 2019 outlook for the sector as the 2018 US Farm Bill law plants the seeds of a new era for the US markets.
According to New Frontier Data, quote, “The 2018 Farm Bill will restore industrial hemp to nationwide legal production for the first time since World War II, offering vast opportunities for the industry and investment in a market expected to triple in four years.” End quote.
With the removal of hemp from federal prohibition under the Controlled Substances Act of 1970, the total U.S. hemp industry now looks to expand at a healthy 18.4% through a 5-year combined annual growth rate from 2018-2022. New Frontier Data’s Hemp Business Journal estimates that, in leading all hemp product categories, the hemp-derived CBD market will grow from a $390 million-dollar market in 2018, to a $1.3 billion market by 2022, representing a 27.2% 5-year CAGR.
SinglePoint, Inc. (OTCQB ticker symbol SING) just stated in recent news, quote, “This is a huge win and opportunity for us. The company’s subsidiary SingleSeed.com is an ecommerce-based business that sells and supplies industrial-based hemp cannabidiol (CBD) products. As hemp has become more mainstream and now a fully federally legal commodity the company plans to add more to its offering. Ranging from Biofuel to construction materials to extracting cannabidiol used to treat various ailments and wellbeing, industrial hemp now has an opportunity to be competitive in the global marketplace. Looking ahead to 2019, SinglePoint management is seeking new deals and currently negotiating potential acquisitions across different sectors and will continue to grow revenue through its acquisition model. Management is confident revenue growth through hemp-based initiatives will be successful through 2019 and beyond,” end quote.
Bruce Linton, Chairman & Co-CEO, Canopy Growth Corporation, the world's largest diversified hemp and cannabis company, (CGC on New York Stock Exchange), commented on the passage of the Farm Bill saying, quote, "Canopy Growth commends the United States government for passing the Farm Bill, a transformative piece of legislation that will create jobs and meaningful economic impact across the United States. Thanks to a deep hemp-specific portfolio of intellectual property acquired from Colorado-based ebbu Inc. and a landmark investment of USD $4 billion from Constellation Brands, management believes it is well-positioned to enter the US market quickly.” End quote.
Canadian-based Tilray, Inc. (NASDAQ ticker symbol TLRY), a global leader in cannabis research and production said in December following a flurry of deal flow, quote, “The Farm Bill in the U.S. presents an opportunity to enter the hemp-derived CBD industry and capitalize on an estimated US$22 billion market. Tilray has the expertise, team and supply in place to pursue this opportunity and looks forward to potentially expanding its product offerings to include hemp-derived CBD in U.S.” End quote.
Another Canadian-based player, with a presence across five continents, Cronos Group (NASDAQ ticker symbol CRON) is on most investors’ watch list following recent news of a C$2.4 billion strategic investment from Altria Group, Inc.
Following the news, during the company’s conference call, Graeme Kreindler from Eight Capital asked about Altria’s experience in the US market and how it would play a role. Quote, “So I was wondering if there’s been any discussions about what that could mean for Cronos in the event of a passing of a farm bill here, on a strategic initiative there?” End Quote.
Cronos Group’s CEO Mike Gorenstein said, quote, “Sure. I think any market, it’s great being able to draw from that experience. One of the things that we found is going to be really important is the experience that Altria has dealing with agencies like the FDA and making sure that, again, we follow all the steps, we follow the right processes to make sure that we’re bringing products on in a responsible fashion and in collaboration with regulators. So I think that will be very, very important for us.” End quote.
With headlines like,’ 'Financial cascade': How the U.S. farm bill could unleash a multi-billion dollar CBD business overnight’ investors are looking to 2019 as a big year for cannabis stocks but as always, are reminded to keep their feet firmly planted in the ground with some due diligence.
Material originally published: otcmarkets.com
About InvestorIdeas.com
This episode is brought to you via Stock Wave - a production company that provides audio & video services to variety of clients. Stock Wave may have been compensated for the production of this audio service.
In trading, there can be no assurance that any prior successes or past results as to income earnings can be used as an indication of future success or results. Audio/video services by Stock Wave are for informational purposes only and do not purport to be a complete study of the featured company or other companies mentioned. Information used and statements of fact have been obtained from the featured company and other sources, but not verified nor guaranteed by Stock Wave, as to completeness or accuracy.
Listeners are advised to use caution and seek the advice of qualified professionals before acting on any information provided by Stock Wave’s audio/video services. Listeners are also advised to perform their own due diligence when it comes to making investment decisions.
Imaging3, Inc. (OTCQB:IGNG, “Imaging3” or the “Company”), a development stage company introducing disruptive technologies in the medical imaging industry, today provided an update on Company progress during 2018 and discussed goals for 2019. For more visit imaging3.com
This episode is brought to you via Stock Wave - a production company that provides audio & video services to variety of clients. Stock Wave may have been compensated for the production of this audio service.
In trading, there can be no assurance that any prior successes or past results as to income earnings can be used as an indication of future success or results. Audio/video services by Stock Wave are for informational purposes only and do not purport to be a complete study of the featured company or other companies mentioned. Information used and statements of fact have been obtained from the featured company and other sources, but not verified nor guaranteed by Stock Wave, as to completeness or accuracy.
Listeners are advised to use caution and seek the advice of qualified professionals before acting on any information provided by Stock Wave’s audio/video services. Listeners are also advised to perform their own due diligence when it comes to making investment decisions.
From the publisher's feed